Nvidia Backs AI Drug Discovery: Unpacking the $50M Investment in Recursion

AI Breakdown

In this episode, we break down Nvidia's strategic move of injecting $50 million into Recursion's AI drug discovery initiatives, analyzing the motives behind this substantial investment and its potential to reshape the healthcare landscape.




See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

More description

In this episode, we break down Nvidia's strategic move of injecting $50 million into Recursion's AI drug discovery initiatives, analyzing the motives behind this substantial investment and its potential to reshape the healthcare landscape.




See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

2024-01-16 9 min
Listen elsewhere

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in

Chapters

No chapters available.